Ataxia telangiectasia is a neurodegenerative disease caused by mutation of the Atm gene. Here we report that ataxia telangiectasia mutated (ATM) deficiency causes nuclear accumulation of histone deacetylase 4 (HDAC4) in neurons and promotes neurodegeneration. Nuclear HDAC4 binds to chromatin, as well as to myocyte enhancer factor 2A (MEF2A) and cAMP-responsive element binding protein (CREB), leading to histone deacetylation and altered neuronal gene expression. Blocking either HDAC4 activity or its nuclear accumulation blunts these neurodegenerative changes and rescues several behavioral abnormalities of ATM-deficient mice. Full rescue of the neurodegeneration, however, also requires the presence of HDAC4 in the cytoplasm, suggesting that the ataxia telangiectasia phenotype results both from a loss of cytoplasmic HDAC4 as well as its nuclear accumulation. To remain cytoplasmic, HDAC4 must be phosphorylated. The activity of the HDAC4 phosphatase, protein phosphatase 2A (PP2A), is downregulated by ATM-mediated phosphorylation. In ATM deficiency, enhanced PP2A activity leads to HDAC4 dephosphorylation and the nuclear accumulation of HDAC4. Our results define a crucial role of the cellular localization of HDAC4 in the events leading to ataxia telangiectasia neurodegeneration.
Ataxia telangiectasia is a hereditary multisystemic disease resulting from mutations in the ATM gene, which encodes a 370-kD member of the phosphatidylinositol 3 (PI3)-kinase family of kinases [1] [2] [3] [4] . The symptoms of ataxia telangiectasia include non-neurological phenotypes such as immune-system defects, germ-cell defects, hypersensitivity to ionizing radiation and increased susceptibility to cancer 2, 3, 5 . However, it is the loss of neuronal cells, the most direct cause of the devastating ataxia, that is arguably the least understood phenotype in this disease. We report a newly discovered role for HDAC4 in this process.
Class I and class IIa histone deacetylases (HDACs) have key roles in brain development and neuron survival [6] [7] [8] [9] [10] . HDAC4 (class IIa) is abundant in neurons, where it is predominantly cytoplasmic [11] [12] [13] . Relevant to the phenotype of ataxia telangiectasia, HDAC4 deficiency in mice is marked by a postnatal atrophy of the cerebellum, with surviving Purkinje cells having a notable reduction in dendritic complexity 14 . HDAC4 is normally phosphorylated by calcium/calmodulin-dependent kinases (CaMKs), enabling its binding to the 14-3-3 family of protein chaperones 7, [15] [16] [17] . HDAC4, like other class IIa HDACs, associates with the prosurvival transcription factors MEF2A and CREB, repressing their transcriptional activity [18] [19] [20] . Though well studied in other cell types, the relationship between HDAC4 and MEF2A-or CREB-dependent gene expression in neurons is largely unexplored.
RESULTS

Nuclear HDAC4 reduces MEF2A/CREB-dependent transcription
The similar phenotypes of neuron death and dendritic atrophy in the cerebella of ATM-or HDAC4-deficient mice 9, 18, 21, 22 prompted us to examine HDAC4 in human ataxia telangiectasia cerebella. Normally, HDAC4 immunoreactivity is found in Purkinje cell cytoplasm ( Fig. 1a) . However, the Purkinje cell nuclei in the ataxia telangiectasia samples had strong HDAC4 staining ( Fig. 1a,b) . The nuclear accumulation of HDAC4 was specific: despite structural and functional similarities to HDAC4 (refs. 23, 24) , HDAC5 and HDAC9 showed little nuclear accumulation in ataxia telangiectasia ( Supplementary  Fig. 1a ). We replicated these observations in mice. HDAC4, but not HDAC5 or HDAC9 (Supplementary Fig. 1b) , showed significant nuclear accumulation in Atm −/− but not wild-type mouse Purkinje cells (Fig. 1a,c) . We found similar shifts in HDAC4 localization in other mouse brain regions, including the neocortex and brain stem ( Supplementary Fig. 1c) . The shift was also seen with exogenous protein; GFP-HDAC4 transfected into cultured Atm −/− neurons also localized to the nucleus (Fig. 1d) . Further, after exposure of cultured cortical neurons to siRNA against Atm, HDAC9 remained in the cytoplasm, whereas endogenous HDAC4 shifted to the nucleus (Supplementary Fig. 1d) .
The association of MEF2A and CREB with HDAC4 was markedly higher in Atm −/− cerebellar extracts than in wild-type extracts (Fig. 1e,f and Supplementary Fig. 2a ). That interaction with HDAC4 served to inactivate MEF2A and CREB because we observed reduced promoter occupancy of these two proteins at known target genes in Atm −/− mice. We performed chromatin immunoprecipitation (ChIP) and assayed by quantitative PCR (qPCR) the extent to which various promoter regions were occupied: Egr3, Fos and Mef2a for MEF2A and Atf, Nrxn1, Nrxn3 and Egr1 for CREB. In each region, we found lower promoter occupancy in the Atm −/− samples compared to the wild-type samples ( Fig. 1g,h) . We next performed electrophoretic mobility shift assays with MEF2A and CREB DNA-binding consensus sequences ( Supplementary Table 1 ). Nuclear extracts from Atm −/− mouse brains showed lower binding to these probes compared to wild-type brains ( Fig. 1i) . Further, the DNA binding of MEF2A and CREB, as well as their supershifts, could be restored in Atm −/− cells by knocking down HDAC4 but not HDAC9 ( Fig. 1i,j) . We determined that the probes were specific ( Supplementary Fig. 2b) , and the shRNAs used for the knockdown were efficacious (Supplementary Fig. 2c ).
Nuclear HDAC4 suppresses neuronal gene expression
Enhanced HDAC4 in Atm −/− neuronal nuclei suggests a reduction of histone acetylation in these cells. Immunostaining for total histone 3 (H3) and H4 in Atm −/− cerebella was similar to that in wild-type cerebella ( Fig. 2a) . By contrast, we found less immunostaining for acetylated histone 3 (AcH3) and AcH4 in Atm −/− mice compared to wild-type mice. We found the same result in the neocortex and hippocampus (Supplementary Fig. 2d ). We confirmed these findings using western blots ( Fig. 2b-d) . We then examined the association of AcH3 and AcH4 with specific gene promoters. We performed ChIP followed by qPCR assays with extracts from wild-type and Atm −/− mouse cerebella ( Fig. 2e-g) . The ChIP of H3 revealed no consistent difference between wild-type and Atm −/− samples in chromatin association at the promoters we examined ( Fig. 2e) . By contrast, the associations of AcH3 and AcH4 with multiple neuronal growth genes were consistently lower in Atm −/− samples compared to wild-type samples. The loss of histone acetylation in a promoter region suggests a closed chromatin configuration and reduced transcription. Accordingly, in Atm −/− compared to wild-type samples, we observed less transcription of multiple neuronal genes at which there was lower promoter occupancy by acetylated histones, for example, Bdnf, Grin2a (also known as Nr2a), Nrxn1 and Nrxn3 ( Fig. 2f-g) . The occupancy of these promoters by H3 ( Fig. 2e ) and H4 (data not shown) in Atm −/− mice was equivalent to that in wild-type mice.
We next performed ChIP with HDAC4 and found that it directly associates with chromatin ( Supplementary Fig. 3a,b) . We analyzed the HDAC4-precipitated DNA with ChIP sequencing (ChIPseq) using a SOLiD DNA fragment library platform. The aligned ChIP-seq tags revealed patterns of HDAC4-chromatin binding that differed substantially between wild-type and Atm −/− mice ( Fig. 2h and Supplementary Fig. 3c ). To validate the ChIP-seq results, we performed ChIP-qPCR of selected genes using primers designed to be within the ChIP-seq-identified Atm −/− peak, as well as primers in two sites flanking the peak by approximately 900 bp ( Supplementary Fig. 3d-g) . All four qPCR assays showed increased HDAC4 binding to the region of the peak predicted by sequencing and peak finding in the Atm −/− samples.
Inhibiting HDAC4 prevents neuronal dysfunction in Atm −/− Our data indicate that shifting the location of HDAC4 from the cytoplasm to the nucleus is neurotoxic. Notably, HDAC4 knockout mice have smaller brains than wild-type mice, suggesting that genetic deletion of HDAC4 is also neurotoxic 14 . To explore this potential discrepancy, we treated Atm −/− and wild-type mice with trichostatin A (TSA), a classic HDAC inhibitor [25] [26] [27] . We used treatment with sodium butyrate, a class I HDAC inhibitor, as a control. After 7 d of TSA treatment, the concentrations of markers of degeneration, such as cleaved caspase-3 and the cell cycle markers proliferating cell nuclear antigen (PCNA) and cyclin D1, were substantially lower than those normally found in Atm −/− cerebellum ( Fig. 3a,b) ; by contrast, the concentrations of neuronal survival proteins were higher ( Fig. 3c,d) . Treatment with sodium butyrate had little effect on the levels of these markers ( Supplementary Fig. 4a,b) .
Atm −/− mice have motor abnormalities that are consistent with cerebellar dysfunction 28 , and our data ( Fig. 3a-d) predicted that treatment with TSA should prevent these abnormalities. We treated wild-type and Atm −/− mice for 3 weeks with either TSA or sodium butyrate. We then trained the mice for 1 week on a rotating rod (rotarod) and tested their motor performance. Both genotypes performed equally well on the rotarod at slow rotation speeds (10 rpm; data not shown). At more strenuous speeds (16 rpm), the performance of the Atm −/− mice was significantly worse than the wild-type mice; after TSA treatment, however, the mutant mice performed similarly to the treated wild-type mice (P < 0.05; Fig. 3e ). We saw a similar effect on spontaneous locomotor activity ( Fig. 3f) , as measured by open-field behavior. The exploratory activity (rearing; Fig. 3g ) of TSA-treated Atm −/− mice was significantly greater than that of untreated Atm −/− mice (P < 0.05) and approached the values found for wild-type mice. Treatment with sodium butyrate had little effect on the performance of Atm −/− mice in any behavioral tests ( Fig. 3e-g) .
Hypophosphorylation of HDAC4 induces its nuclear accumulation
To determine whether HDAC4 has a role in the neuronal DNA damage response, we exposed cultures of wild-type and Atm −/− neurons to low doses of etoposide, a topoisomerase inhibitor known to induce DNA double-strand breaks. This exposure enhanced the activation of caspase-3, but this effect was tenfold greater in Atm −/− neurons than in wild-type neurons (Fig. 4a,b) . When we used shRNA against HDAC4 in addition to (and at the same time as) the etoposide exposure, however, the cell death induced by etoposide increased in the wild-type neurons, but the shRNA had little effect on cell death in the Atm −/− neurons (Fig. 4a,b) . Thus, loss of cytoplasmic HDAC4 makes neurons more sensitive to DNA damage. However, HDAC4 itself does not respond to DNA damage. We exposed wildtype and Atm −/− mice to 5 Gy of whole-body irradiation, which activated ATM in wildtype mice but not in Atm −/− mutant mice (Fig. 4c) . The cytoplasmic location of HDAC4 nonetheless was unchanged after irradiation in mice of both genotypes (Fig. 4c) .
We prepared cytoplasmic and nuclear fractions from wild-type and Atm −/− mouse cerebella and probed them with an antibody against phosphorylated Ser632 (phospho-Ser632) of HDAC4 or total HDAC4. In the wild-type cerebellum, most of the HDAC4 was cytoplasmic and phosphorylated ( Fig. 4d,e ). In the Atm −/− cerebellum, however, a large portion of the HDAC4 was nuclear and was almost entirely unphosphorylated at that location. The total HDAC4 was the same in wild-type and Atm −/− mice (Fig. 4d,e ). Homogenates of human ataxia telangiectasia cerebellar samples behaved similarly to the Atm −/− mouse samples (Fig. 4f) , and the use of a second HDAC4 phosphospecific antibody (to phospho-Ser246) confirmed the phospho-Ser632 results (Fig. 4f) . The lower amount of HDAC4 phosphorylation in Atm −/− mice compared to wild-type mice led to a lower association of HDAC4 with the 14-3-3 protein, as assayed by coimmunoprecipitation from human ataxia telangiectasia cerebellum (Fig. 4g,h) and Atm −/− mouse brain ( Supplementary Fig. 5a,b) .
We could find no canonical Ser/Thr-Gln ATM target site on HDAC4 itself or on the kinases responsible for its phosphorylation, CaMKII and CaMKIV 7, 17, 29 . Therefore, we asked whether the HDAC4 protein phosphatase, PP2A 30 , was involved in the hypophosphorylation of HDAC4 in Atm −/− mice. PP2A is a heterotrimeric protein 31 that must associate with its enzymatic target for full phosphatase activity. It consists of a structural A subunit (PP2A-A, also known as PR65), a tissue-specificity-regulatory B subunit (PP2A-B, also known as PR55) and a catalytic C subunit (PP2A-C, also known as Pp2ca). Immunoprecipitations of HDAC4 from human control lysates revealed little interaction of HDAC4 with either the PP2A-A or PP2A-C subunit. By contrast, in the patients with ataxia telangiectasia, we observed a robust association of HDAC4 with both the A and C subunits of PP2A (Fig. 4i) . We also found this greater HDAC4-PP2A association in the Atm −/− mouse brain ( Supplementary  Fig. 5c ). Thus, the lower phosphorylation of HDAC4 in ATMdeficiency is likely caused by a greater association of HDAC4 with its phosphatase, PP2A.
PP2A mediates ATM-dependent HDAC4 nuclear translocation Ser401 of PP2A-A is a highly probable site of ATM phosphorylation 32 . We therefore performed immunoprecipitation with antibodies to PP2A-A, PP2A-C or HDAC4 and probed the resulting western blots with an antibody to phosphorylated serine or threonine preceding a glutamine residue (phospho-Ser/Thr-Gln), the canonical ATM and ataxia telangiectasia and Rad3 related (ATR) target binding site. We found a strong phospho-Ser/Thr-Gln signal on the PP2A-A band from wild-type but not Atm −/− mice on the western blot ( Fig. 5a) .
We found no phospho-Ser/Thr-Gln signal for either wild-type or Atm −/− mice with the PP2A-C or HDAC4 immunoprecipitates ( Fig. 5a) . As further proof that HDAC4 itself is not an ATM substrate, we also found no phospho-Ser/Thr-Gln signal in N2a cells overexpressing Flag-tagged HDAC4 (Flag-HDAC4) (Supplementary Fig. 6a ). We verified that Ser401 is the predominant ATM phosphorylation site on PP2A using in vitro kinase assays (Fig. 5b) ; a form of PP2A-A carrying the S401A mutation could not be phosphorylated by ATM. We overexpressed Flag-HDAC4 with GFP-tagged isoforms of PP2A-A and analyzed the Flag-HDAC4 immunoprecipitates for the presence of PP2A-A. We found a strong HDAC4-PP2A association in the nonphosphorylatable (S401A) PP2A-A isoform (S401A) (Fig. 5c ) but not in wild type or in the phosphomimetic isoform (S401D) (Fig. 5c) . We confirmed this result by probing PP2A-A immunoprecipitates for Flag-HDAC4 (Fig. 5c) . ATM-dependent phosphorylation of PP2A-A also alters the localization of the PP2A holoenzyme itself. Endogenous PP2A-A was predominantly cytoplasmic in wild-type neurons but was predominantly nuclear in Atm −/− neurons (Fig. 5d) . In wild-type primary neurons, when we coexpressed mutant or wild-type GFP-PP2A-A with mCherry-tagged PP2A-C (mCherry-PP2A-C), both subunits were located primarily in the cytoplasm (Fig. 5e) . In Atm −/− neurons, however, unmodified PP2A-A and PP2A-C translocated to the nucleus, whereas the S401D PP2A-A mutant was located predominantly in the cytoplasm, even in ATM-deficient neurons. The S401A PP2A-A mutant was nuclear in both wild-type and Atm −/− neurons (Fig. 5e) . In contrast, the locations of the HDAC4 kinases CaMKII and CaMKIV were unaffected by ATM deficiency (data not shown).
We inhibited ATM activity with 2 mM caffeine or 10 µM KU-55933. Both inhibitors caused HDAC4 to move from cytoplasm to nucleus within 3 h of administration ( Fig. 5f and Supplementary Fig. 6b ). This translocation of HDAC4 could be blocked by simultaneously knocking down PP2A ( Fig. 5g and Supplementary Fig. 6c ) or by pretreating the cells with the PP2A inhibitor endothall ( Fig. 5h and  Supplementary Fig. 6d) . The genotype-dependent nuclear translocation of endogenous HDAC4 could also be blocked by infecting Atm −/− neurons with Pr65 (also known as Ppp2r1a) or Pp2ca shRNAs (Fig. 5h) .
Cytoplasmic HDAC4 improves the phenotype of Atm −/− To verify that cytoplasmic HDAC4 prevents cell cycle reentry and other degenerative changes in Atm −/− mice, we co-injected lentiviral particles encoding human wild-type HDAC4, a nuclear localization HDAC4 mutant (4A, which has the R269A, R280A, K280A and R281A mutations), a nuclear export mutant (L1062A) or a nonphosphorylatable mutant (3SA, which has the S246A, S467A and S632A mutations) together with Hdac4 shRNA (which is specific for the mouse Hdac4 message; Supplementary Fig. 7a,b) into the cerebella of wild-type and Atm −/− mice. One week after injection of the two lentiviruses, we monitored gene transfer by immunohistochemistry using a human-specific antibody to HDAC4 (Supplementary Fig. 7c,d) . In Atm −/− cerebellar neurons infected with the two lentiviruses, cytoplasmic HDAC4 (4A) prevented cell cycle reentry and caspase-3 activation ( Fig. 6a,b) . By contrast, nuclear HDAC4 (L1062A and 3SA) resulted in cell cycle reentry and caspase-3 activation in both Atm −/− and wild-type lentivirus-infected mice (Fig. 6a,b) . Reduced histone acetylation accompanied the higher concentration of nuclear HDAC4 in Atm −/− compared to wild-type mice, as confirmed by immunocytochemistry of AcH3 (Supplementary Fig. 7e ). Overexpression of unmodified human HDAC4 had little effect on either wild-type or Atm −/− neurons.
In primary neurons, overexpression of HDAC4 showed that neuronal cell cycle activity was tightly correlated with the presence of HDAC4 nuclear localization (Supplementary Fig. 6e,f) . Cytoplasmic HDAC4 (4A) was protective and prevented Atm −/− neuronal cell cycle reentry. This offered us the opportunity to separately test the functions of nuclear and cytoplasmic HDAC4 and relate each to the presence or absence of behavioral abnormalities in Atm −/− mice. We co-injected lentiviruses encoding Hdac4 shRNA (against the Hdac4 mouse message) together with viruses encoding exclusively cytoplasmic HDAC4 (H4) into mouse cerebellum at postnatal day (P) 18. At this age, the area infected by the virus should be larger than that infected after a comparable injection into an adult mouse. At P39, when the transgene expression is maximal, we subjected the mice to the same training and trials described above. Atm −/− mice injected with cytoplasmic 4A were able to stay on the rotarod significantly longer (P < 0.05) than Atm −/− sham-injected mice (Fig. 6c) , and the results of the spontaneous locomotor activity observed in the open-field test were consistent with this difference (Fig. 6d) . The exploratory activity (Fig. 6e) of 4A-injected Atm −/− mice was significantly greater (P < 0.05) than the activity of mice injected with nuclear L1062A (Fig. 6d,e ). L1062A-injected wild-type mice performed substantially worse than sham-injected wild-type mice ( Fig. 6c-e ). To test the involvement of PP2A in these results, we injected a lentivirus carrying wild-type PP2A-A or the PP2A-A S401A or S401D isoform into both wild-type and Atm −/− cerebella. The PP2A-A S401D mutant blocked HDAC4 nuclear translocation and inhibited cell-cycle and capase-3 activation. However, wild-type PP2A-A and the PP2A-A S401A mutant had little effect on these activities (Supplementary Fig. 8 a,b) . The effect of the PP2A-A S401D mutant on the behavioral abnormalities in the Atm −/− mice, however, was modest ( Fig. 6c-e ). This might be a result of the broad range of substrates whose phosphorylation would be changed by PP2A activity as well as of the indirect nature of the effect of PP2A on the ataxia telangiectasia phenotype.
DISCUSSION
Our data provide insights into the functions of both ATM and HDAC4 in the health and survival of central nervous system neurons. HDAC4 is normally maintained in the neuronal cytoplasm through its interaction with the 14-3-3 protein. This interaction requires CaMKII-or CaMKIV-mediated HDAC4 phosphorylation. ATM plays an essential part in the cytoplasmic retention of HDAC4, but its action is indirect. It targets neither the CaMK kinases nor HDAC4 itself. Rather, it suppresses the HDAC4 phosphatase, PP2A, by phosphorylating Ser401 of the PP2A-A subunit (Supplementary Fig. 8c-e ). In ATM deficiency, hypophosphorylated HDAC4 translocates to the nucleus, where it triggers a decrease in histone H3 and H4 acetylation and large-scale changes in the pattern of gene expression. This study uncovers several major features of the epigenetic landscape of the Atm −/− neuronal genome. First, our ChIP analysis showed genome-wide changes in the location of AcH3 and AcH4 in Atm −/− mice compared to wild-type mice, which is in contrast to the results seen with unmodified histone H3 or H4. Second, by performing ChIP-seq with antibodies to HDAC4, we provide data in support of the idea that HDAC4 is itself associated with specific genomic locations and that these locations differ depending on the Atm genotype of the neuron. Most models of HDAC4 action are based on its binding to and inhibiting proteins, such as MEF2A, thus decreasing their effective concentration at the promoters of key target genes 33, 34 . Our ChIP and HDAC4 ChIP-seq data suggest that in the absence of ATM, HDAC4 accumulates in the nucleus, where it directly associates with chromatin. Although HDAC4 may remain associated with MEF2A, CREB or both, which is suggested by the increased binding of nuclear HDAC4 (3SA and L1062A) to MEF2A and CREB in Atm −/− mice, it can be described as a full participant in transcriptional suppression. We emphasized this point by comparing the chromatin-binding patterns of HDAC4 with those of AcH3 and AcH4 or of MEF2A and CREB alone. Several neuronal genes, such as Creb, Mef2A and Bdnf, have a reduced association with AcH3 and AcH4 or MEF2A and CREB but show high amounts of association with HDAC4 itself. Third, in the promoter region of each genetic locus we examined, the changes in gene transcription predicted by a more open conformation in the presence of acetylated histone proteins were borne out by the results from both the RT-PCR and western blot analyses. This suggests that key aspects of the neuronal phenotypes observed in ataxia telangiectasia and in Atm −/− mice are caused not only by the absence of the ATM kinase activity itself but also by the indirect epigenetic changes in the pattern of histone acetylation and transcription factor inhibition that occur as a result of the presence of nuclear HDAC4.
This concept suggests several new targets for pharmacological intervention in the treatment of ataxia telangiectasia. For example, inhibiting HDAC4 activity and blocking its nuclear accumulation both reverse the altered histone acetylation pattern and rescue various aspects of the neurodegenerative phenotype of mouse ATMdeficient neurons. Particularly noteworthy is the phenotypic rescue of both the neurodegenerative changes of Atm −/− cerebellar neurons in vivo as well as the improvements in motor behavior when HDAC4 nuclear activity is inhibited or when cytoplasmic HDAC4 is overexpressed. The lentivirus injection studies illustrate this concept on a cell-by-cell basis; the TSA injections make the same point on the level of the whole brain. TSA is admittedly a very broad spectrum HDAC inhibitor, however, the reversal of cell cycle protein expression as a result of TSA treatment was noteworthy. In addition, the failure of sodium butyrate to elicit a comparable effect suggests no involvement of class I HDAC activities. This picture of a two-edged sword-neuroprotection of HDAC4 in the cytoplasm but neurotoxicity of HDAC4 in the nucleus-suggests that it may be more strategic to focus on HDAC4 location rather than HDAC4 activity as the most useful ataxia telangiectasia therapeutic target.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
